Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)
AuthorKiely, David G
Ivy, David D
Kawut, Steven M
Puri, Goverdhan Dutt
Van Beek, Edwin Jr
Vanderpool, Rebecca R
Swift, Andrew J
AffiliationUniv Arizona, Div Translat & Regenerat Med
magnetic resonance imaging
MetadataShow full item record
PublisherSAGE PUBLICATIONS INC
CitationKiely, D. G., Levin, D. L., Hassoun, P. M., Ivy, D., Jone, P.-N., Bwika, J., … Swift, A. J. (2019). Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI). Pulmonary Circulation. https://doi.org/10.1177/2045894019841990
RightsCopyright © The Author(s) 2019. Creative Commons CC-BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractPulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it remains a life-shortening condition. There have been significant advances in imaging technologies, but despite evidence of their potential clinical utility, practice remains variable, dependent in part on imaging availability and expertise. This statement summarizes current and emerging imaging modalities and their potential role in the diagnosis and assessment of suspected PH. It also includes a review of commonly encountered clinical and radiological scenarios, and imaging and modeling-based biomarkers. An expert panel was formed including clinicians, radiologists, imaging scientists, and computational modelers. Section editors generated a series of summary statements based on a review of the literature and professional experience and, following consensus review, a diagnostic algorithm and 55 statements were agreed. The diagnostic algorithm and summary statements emphasize the key role and added value of imaging in the diagnosis and assessment of PH and highlight areas requiring further research.
NoteOpen access article
VersionFinal published version
SponsorsWellcome TrustWellcome Trust [R/148654-11-1]
- Endothelin-A receptor blockade in porcine pulmonary hypertension.
- Authors: Ambalavanan N, Philips JB 3rd, Bulger A, Oparil S, Chen YF
- Issue date: 2002 Dec
- Non-invasive determination by cardiovascular magnetic resonance of right ventricular-vascular coupling in children and adolescents with pulmonary hypertension.
- Authors: Truong U, Patel S, Kheyfets V, Dunning J, Fonseca B, Barker AJ, Ivy D, Shandas R, Hunter K
- Issue date: 2015 Sep 16
- Pulmonary vascular resistance index: Getting the units right and why it matters.
- Authors: Kwan WC, Shavelle DM, Laughrun DR
- Issue date: 2019 Mar
- Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research Institute (PVRI).
- Authors: Lopes AA, Barst RJ, Haworth SG, Rabinovitch M, Al Dabbagh M, Del Cerro MJ, Ivy D, Kashour T, Kumar K, Harikrishnan S, D'Alto M, Thomaz AM, Zorzanelli L, Aiello VD, Mocumbi AO, Santana MV, Galal AN, Banjar H, Tamimi O, Heath A, Flores PC, Diaz G, Sandoval J, Kothari S, Moledina S, Gonçalves RC, Barreto AC, Binotto MA, Maia M, Al Habshan F, Adatia I
- Issue date: 2014 Jun
- Comparative outcome of bidirectional Glenn shunt in patients with pulmonary vascular resistance > or = 3.5 woods units versus < 3.5 woods units.
- Authors: Hussain A, Arfi AM, Hussamuddin M, Haneef AA, Jamjoom A, Al-Ata J, Mo G
- Issue date: 2008 Oct 1